Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03997838 · ClinicalTrials.gov registry record · Phase 3
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty
A Phase 3 study, sponsored by Vivozon.
- Completed
- Registry status
- Phase 3
- Development phase
- 307
- Enrollment target
NCT03997838 is a Phase 3 study that has completed, run by Vivozon. The registered enrollment target is 307 participants.
The verdict
NCT03997838, a Phase 3 study, has completed, sponsored by Vivozon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 307 participants
- Enrollment target
Study Summary
The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.
Interventions
- DRUG Placebo
- DRUG VVZ-149 Injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2019-08-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03997838
The ClinicalTrials.gov registry entry for NCT03997838 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivozon, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03997838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03997838 about?
NCT03997838 is a clinical study titled "Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty". The purpose of this phase 3 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following abdominoplasty.
What is the current status of trial NCT03997838?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 307 participants. The study started on 2019-05-23. Estimated completion is 2019-08-21.
What interventions are being tested in trial NCT03997838?
The interventions under investigation include: Placebo (DRUG), VVZ-149 Injections (DRUG).
Who is sponsoring clinical trial NCT03997838?
This trial is sponsored by Vivozon, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.